Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova et al. · Cell Reports · 2017 · 5.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Lanxiang Huang, Yuan Rong, Xuan Tang et al. · Molecular Cancer · 2022 · 394 citations · Full text

Medicine, Immunology, Oncology +17

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer

Lina Liu, Yuhua Wang, Lei Miao et al. · Molecular Therapy · 2017 · 370 citations · Full text

Medicine, Immunology, Oncology +17

Targeting a neoantigen derived from a common <i>TP53</i> mutation

Emily Han-Chung Hsiue, Katharine M. Wright, Jacqueline Douglass et al. · Science · 2021 · 347 citations · Full text

Life Sciences, Genetics, Oncology +14

MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer

Takahiro Maeda, Masayuki Hiraki, Caining Jin et al. · Cancer Research · 2017 · 274 citations · Full text

Medicine, Cancer Biology, Oncology +17